Regulation of potential-dependent L-type Ca2+ currents by agmatine. Imidazoline receptors in isolated cardiomyocytes

A. V. Maltsev, E. V. Evdokimovskii, O. Yu Pimenov, M. N. Nenov, Yu M. Kokoz

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The main goal of the present work was to study the mechanisms of voltage-gated L-type Ca2+ currents regulation by agmatine in isolated cardiomyocytes and to determine whether agmatine is involved in mediating the "arginine paradox". It was shown that agmatine at concentrations from 200 μM to 15 mM inhibited L-type Ca2+ currents in isolated cardiomyocytes in a dose-dependent manner. The selective antagonists of α2-adrenoceptors (α2-ARs), yohimbine and rauwolscine, did not modulate the effect of agmatine. In contrast, efaroxan and idazoxan known to antagonize both α2-ARs and type 1 imidazoline receptors (I1Rs) decreased the efficiency of agmatine almost twofold. The NO synthase inhibitor 7NI insignificantly influenced the suppressive action of agmatine on L-type Ca2+ currents, whereas the protein kinase C inhibitor, calphostin C, markedly reduced the effects of agmatine. Arginine did not affect L-type Ca2+ currents in the presence of agmatine and vice versa. These data suggest that agmatine is not involved in mediating the "arginine paradox" and that its effects are not due to the activation of endothelial NO synthase (eNOS) followed by cGMP-dependent inhibition of L-type Ca2+ current. Most likely, agmatine acts via I1Rs coupled with the signaling pathway that involves the activation of protein kinase C. Previously nothing was known about possible localization of I1Rs in isolated cardiomyocytes. Consistently, we have shown that single cardiomyocytes express the nischarin genes homologous to the IRAS gene, which is considered in the modern literature as the major candidate for the gene encoding I1Rs. To the best our knowledge, this is the first demonstration of I1Rs expression at the level of individual cells, including cardiomyocytes.

Original languageEnglish (US)
Pages (from-to)279-287
Number of pages9
JournalBiochemistry (Moscow) Supplement Series A: Membrane and Cell Biology
Volume6
Issue number4
DOIs
StatePublished - Oct 2012
Externally publishedYes

Fingerprint

Imidazoline Receptors
Agmatine
Cardiac Myocytes
Arginine
efaroxan
Yohimbine
Nitric Oxide Synthase
Adrenergic Receptors
Protein Kinase C
Modern Literature
Genes
Chemical activation
Idazoxan
Gene encoding
Protein C Inhibitor
Protein Kinase Inhibitors
Demonstrations

Keywords

  • agmatine
  • Ca current
  • imidazoline receptors

ASJC Scopus subject areas

  • Biochemistry
  • Biophysics
  • Cell Biology

Cite this

Regulation of potential-dependent L-type Ca2+ currents by agmatine. Imidazoline receptors in isolated cardiomyocytes. / Maltsev, A. V.; Evdokimovskii, E. V.; Pimenov, O. Yu; Nenov, M. N.; Kokoz, Yu M.

In: Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology, Vol. 6, No. 4, 10.2012, p. 279-287.

Research output: Contribution to journalArticle

Maltsev, A. V. ; Evdokimovskii, E. V. ; Pimenov, O. Yu ; Nenov, M. N. ; Kokoz, Yu M. / Regulation of potential-dependent L-type Ca2+ currents by agmatine. Imidazoline receptors in isolated cardiomyocytes. In: Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology. 2012 ; Vol. 6, No. 4. pp. 279-287.
@article{71c9c91e1c334395adcb461fe0f9f82e,
title = "Regulation of potential-dependent L-type Ca2+ currents by agmatine. Imidazoline receptors in isolated cardiomyocytes",
abstract = "The main goal of the present work was to study the mechanisms of voltage-gated L-type Ca2+ currents regulation by agmatine in isolated cardiomyocytes and to determine whether agmatine is involved in mediating the {"}arginine paradox{"}. It was shown that agmatine at concentrations from 200 μM to 15 mM inhibited L-type Ca2+ currents in isolated cardiomyocytes in a dose-dependent manner. The selective antagonists of α2-adrenoceptors (α2-ARs), yohimbine and rauwolscine, did not modulate the effect of agmatine. In contrast, efaroxan and idazoxan known to antagonize both α2-ARs and type 1 imidazoline receptors (I1Rs) decreased the efficiency of agmatine almost twofold. The NO synthase inhibitor 7NI insignificantly influenced the suppressive action of agmatine on L-type Ca2+ currents, whereas the protein kinase C inhibitor, calphostin C, markedly reduced the effects of agmatine. Arginine did not affect L-type Ca2+ currents in the presence of agmatine and vice versa. These data suggest that agmatine is not involved in mediating the {"}arginine paradox{"} and that its effects are not due to the activation of endothelial NO synthase (eNOS) followed by cGMP-dependent inhibition of L-type Ca2+ current. Most likely, agmatine acts via I1Rs coupled with the signaling pathway that involves the activation of protein kinase C. Previously nothing was known about possible localization of I1Rs in isolated cardiomyocytes. Consistently, we have shown that single cardiomyocytes express the nischarin genes homologous to the IRAS gene, which is considered in the modern literature as the major candidate for the gene encoding I1Rs. To the best our knowledge, this is the first demonstration of I1Rs expression at the level of individual cells, including cardiomyocytes.",
keywords = "agmatine, Ca current, imidazoline receptors",
author = "Maltsev, {A. V.} and Evdokimovskii, {E. V.} and Pimenov, {O. Yu} and Nenov, {M. N.} and Kokoz, {Yu M.}",
year = "2012",
month = "10",
doi = "10.1134/S1990747812040058",
language = "English (US)",
volume = "6",
pages = "279--287",
journal = "Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology",
issn = "1990-7478",
publisher = "Maik Nauka-Interperiodica Publishing",
number = "4",

}

TY - JOUR

T1 - Regulation of potential-dependent L-type Ca2+ currents by agmatine. Imidazoline receptors in isolated cardiomyocytes

AU - Maltsev, A. V.

AU - Evdokimovskii, E. V.

AU - Pimenov, O. Yu

AU - Nenov, M. N.

AU - Kokoz, Yu M.

PY - 2012/10

Y1 - 2012/10

N2 - The main goal of the present work was to study the mechanisms of voltage-gated L-type Ca2+ currents regulation by agmatine in isolated cardiomyocytes and to determine whether agmatine is involved in mediating the "arginine paradox". It was shown that agmatine at concentrations from 200 μM to 15 mM inhibited L-type Ca2+ currents in isolated cardiomyocytes in a dose-dependent manner. The selective antagonists of α2-adrenoceptors (α2-ARs), yohimbine and rauwolscine, did not modulate the effect of agmatine. In contrast, efaroxan and idazoxan known to antagonize both α2-ARs and type 1 imidazoline receptors (I1Rs) decreased the efficiency of agmatine almost twofold. The NO synthase inhibitor 7NI insignificantly influenced the suppressive action of agmatine on L-type Ca2+ currents, whereas the protein kinase C inhibitor, calphostin C, markedly reduced the effects of agmatine. Arginine did not affect L-type Ca2+ currents in the presence of agmatine and vice versa. These data suggest that agmatine is not involved in mediating the "arginine paradox" and that its effects are not due to the activation of endothelial NO synthase (eNOS) followed by cGMP-dependent inhibition of L-type Ca2+ current. Most likely, agmatine acts via I1Rs coupled with the signaling pathway that involves the activation of protein kinase C. Previously nothing was known about possible localization of I1Rs in isolated cardiomyocytes. Consistently, we have shown that single cardiomyocytes express the nischarin genes homologous to the IRAS gene, which is considered in the modern literature as the major candidate for the gene encoding I1Rs. To the best our knowledge, this is the first demonstration of I1Rs expression at the level of individual cells, including cardiomyocytes.

AB - The main goal of the present work was to study the mechanisms of voltage-gated L-type Ca2+ currents regulation by agmatine in isolated cardiomyocytes and to determine whether agmatine is involved in mediating the "arginine paradox". It was shown that agmatine at concentrations from 200 μM to 15 mM inhibited L-type Ca2+ currents in isolated cardiomyocytes in a dose-dependent manner. The selective antagonists of α2-adrenoceptors (α2-ARs), yohimbine and rauwolscine, did not modulate the effect of agmatine. In contrast, efaroxan and idazoxan known to antagonize both α2-ARs and type 1 imidazoline receptors (I1Rs) decreased the efficiency of agmatine almost twofold. The NO synthase inhibitor 7NI insignificantly influenced the suppressive action of agmatine on L-type Ca2+ currents, whereas the protein kinase C inhibitor, calphostin C, markedly reduced the effects of agmatine. Arginine did not affect L-type Ca2+ currents in the presence of agmatine and vice versa. These data suggest that agmatine is not involved in mediating the "arginine paradox" and that its effects are not due to the activation of endothelial NO synthase (eNOS) followed by cGMP-dependent inhibition of L-type Ca2+ current. Most likely, agmatine acts via I1Rs coupled with the signaling pathway that involves the activation of protein kinase C. Previously nothing was known about possible localization of I1Rs in isolated cardiomyocytes. Consistently, we have shown that single cardiomyocytes express the nischarin genes homologous to the IRAS gene, which is considered in the modern literature as the major candidate for the gene encoding I1Rs. To the best our knowledge, this is the first demonstration of I1Rs expression at the level of individual cells, including cardiomyocytes.

KW - agmatine

KW - Ca current

KW - imidazoline receptors

UR - http://www.scopus.com/inward/record.url?scp=84875869565&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84875869565&partnerID=8YFLogxK

U2 - 10.1134/S1990747812040058

DO - 10.1134/S1990747812040058

M3 - Article

AN - SCOPUS:84875869565

VL - 6

SP - 279

EP - 287

JO - Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology

JF - Biochemistry (Moscow) Supplement Series A: Membrane and Cell Biology

SN - 1990-7478

IS - 4

ER -